Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements - Additional Information (Details)

v3.23.3
Fair Value Measurements - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended
Jul. 16, 2021
Jul. 15, 2021
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities     $ 39,487 $ 0
Recurring Basis | Treasury bills        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
U.S. treasury bills with maturities less than three months     $ 9,900  
Public Warrant        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Warrant exercisable (in shares)     14,325,000  
Warrants exercise price (in dollars per share)     $ 11.50  
Warrants outstanding (in shares)     14,324,893  
Contingent earn-out liability | Measurement Input, Price Volatility        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     87.50%  
Contingent earn-out liability | Measurement Input, Risk Free Interest Rate        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     4.90%  
Contingent earn-out liability | Change in control        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     25.00%  
Contingent earn-out liability | Measurement Input, Expected Term        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration term     2 years 4 months 24 days  
Contingently issuable common stock liability        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) 517,500 4,312,500    
Shares vested (in shares) 1,897,500      
Outstanding shares expected to vest (in shares)     1,897,500  
Contingently issuable common stock liability | Measurement Input, Price Volatility        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     87.50%  
Contingently issuable common stock liability | Measurement Input, Risk Free Interest Rate        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     4.80%  
Contingently issuable common stock liability | Change in control        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     25.00%  
Contingently issuable common stock liability | Measurement Input, Expected Term        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration term     2 years 9 months 18 days